A set of molecular biomarkers might better predict the recurrence of bladder cancer than conventional prognostic features such as the stage or grade of the malignancy at the time it is discovered, UT Southwestern Medical Center researchers have found.
AkaRx, Inc., a Paramus, New Jersey biopharmaceutical company announced today that they have licensed from BeartownPharma, Inc., of Underhill, Vermont the patents for a new drug being developed for the treatment of patients with thyroid cancer.
Now, a specific region rife with promise has been located on one chromosome by a consortium of researchers working under Douglas Levinson, MD, professor of psychiatry and behavioral sciences at the Stanford University School of Medicine.
Measurements of brainwaves in kids with extreme irritability suggest that different brain mechanisms are at play, depending on the disorders the kids have. This finding brings us a step closer to the day when clinicians can use biological measurements — rather than depending only on behavioral symptoms or self-reports — to diagnose psychiatric disorders.
A woman’s risk of dying after a heart attack or stroke is higher than a man’s, according to Report Cards on Health – 2007 Report on Canadians’ Health by The Heart and Stroke Foundation of Canada.
A genetic test may help to monitor dose of psycho-stimulant drugs like Ritalin to ADHD children, revealed by Australian health expert.
Rats that rode in a truck on the New York State Thruway between Rochester and Buffalo and were exposed to the same highway pollution that motorists encounter, showed a drop in heart rate and effects on the autonomic nervous system, according to a study published this month in the journal Inhalation Toxicology.
HIV prevention advocates from three major civil society organizations today emphasized the importance of continued research into new HIV prevention options, despite the recent discontinuation of the phase III effectiveness trials of the microbicide candidate, cellulose sulfate (CS).
Wounds in the mouth heal more slowly in women and older adults, a new study at the University of Illinois at Chicago reveals.
Researchers have begun a clinical study of oral insulin to prevent or delay type 1 diabetes in at-risk people, the National Institutes of Health (NIH) announced today.